Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126331611 | 12633161 | 1 | I | 0 | 20160808 | 20160808 | DIR | 24.00 | YR | M | N | 165.00000 | LBS | 20160806 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126331611 | 12633161 | 1 | PS | KEPPRA | LEVETIRACETAM | 1 | Oral | N | D | 0 | BID | ||||||||
| 126331611 | 12633161 | 2 | SS | TEGRETOL XR | CARBAMAZEPINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126331611 | 12633161 | 1 | Benign rolandic epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126331611 | 12633161 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126331611 | 12633161 | Activities of daily living impaired | |
| 126331611 | 12633161 | Anger | |
| 126331611 | 12633161 | Anxiety | |
| 126331611 | 12633161 | Disturbance in attention | |
| 126331611 | 12633161 | Disturbance in social behaviour | |
| 126331611 | 12633161 | Impaired work ability | |
| 126331611 | 12633161 | Irritability | |
| 126331611 | 12633161 | Therapy cessation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126331611 | 12633161 | 1 | 10 | YR |